BSE Live
Dec 22, 16:01Prev. Close
25.19
Open Price
23.94
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 22, 15:58Prev. Close
25.27
Open Price
24.01
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
24.01 (115777)
| Key Financial Ratios of Vivimed Labs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 11.69 | 16.43 | 22.87 | 29.00 | 27.31 | |
| Diluted EPS (Rs.) | 11.69 | 16.43 | 22.87 | 25.16 | 23.82 | |
| Cash EPS (Rs.) | 24.37 | 27.58 | 33.59 | 36.58 | 33.30 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 230.16 | 230.68 | 215.08 | 199.02 | 150.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 230.78 | 231.30 | 215.71 | 199.74 | 151.43 | |
| Dividend / Share(Rs.) | 0.00 | 3.00 | 3.00 | 3.00 | 2.00 | |
| Revenue from Operations/Share (Rs.) | 265.46 | 266.60 | 263.45 | 274.80 | 304.81 | |
| PBDIT/Share (Rs.) | 66.13 | 62.46 | 60.41 | 60.59 | 55.76 | |
| PBIT/Share (Rs.) | 53.44 | 51.32 | 49.70 | 53.02 | 49.78 | |
| PBT/Share (Rs.) | 14.97 | 23.95 | 31.99 | 36.85 | 32.44 | |
| Net Profit/Share (Rs.) | 11.69 | 16.43 | 22.87 | 29.00 | 27.32 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.91 | 23.42 | 22.93 | 22.04 | 18.29 | |
| PBIT Margin (%) | 20.13 | 19.24 | 18.86 | 19.29 | 16.33 | |
| PBT Margin (%) | 5.63 | 8.98 | 12.14 | 13.40 | 10.64 | |
| Net Profit Margin (%) | 4.40 | 6.16 | 8.68 | 10.55 | 8.96 | |
| Return on Networth / Equity (%) | 5.07 | 7.12 | 10.63 | 14.57 | 18.15 | |
| Return on Capital Employed (%) | 2.23 | 3.27 | 5.92 | 7.95 | 10.84 | |
| Return on Assets (%) | 1.45 | 2.15 | 3.84 | 5.19 | 6.47 | |
| Total Debt/Equity (X) | 1.59 | 1.52 | 1.19 | 1.24 | 1.49 | |
| Asset Turnover Ratio (%) | 33.01 | 34.95 | 44.31 | 49.24 | 72.30 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.39 | 1.41 | 1.33 | 1.33 | 1.49 | |
| Quick Ratio (X) | 0.90 | 1.01 | 0.91 | 1.06 | 1.10 | |
| Inventory Turnover Ratio (X) | 1.93 | 2.54 | 3.01 | 5.18 | 4.64 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 18.25 | 11.42 | 10.34 | 7.32 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 10.87 | 7.78 | 8.20 | 6.00 | |
| Earnings Retention Ratio (%) | 100.00 | 81.75 | 88.58 | 89.66 | 92.68 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 89.13 | 92.22 | 91.80 | 94.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,175.61 | 841.17 | 845.93 | 956.01 | 485.69 | |
| EV/Net Operating Revenue (X) | 2.73 | 1.95 | 2.00 | 2.50 | 1.57 | |
| EV/EBITDA (X) | 10.97 | 8.31 | 8.72 | 11.32 | 8.57 | |
| MarketCap/Net Operating Revenue (X) | 1.38 | 0.66 | 1.06 | 1.48 | 0.86 | |
| Retention Ratios (%) | 100.00 | 81.74 | 88.57 | 89.65 | 92.67 | |
| Price/BV (X) | 1.60 | 0.77 | 1.30 | 2.04 | 1.75 | |
| Price/Net Operating Revenue | 1.38 | 0.66 | 1.06 | 1.48 | 0.86 | |
| Earnings Yield | 0.03 | 0.09 | 0.08 | 0.07 | 0.10 |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y